Teladoc, Inc. (NYSE:TDOC) insider Adam C. Vandervoort sold 53,806 shares of the firm’s stock in a transaction on Monday, August 7th. The shares were sold at an average price of $30.92, for a total transaction of $1,663,681.52. Following the completion of the transaction, the insider now directly owns 33,008 shares of the company’s stock, valued at $1,020,607.36. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

Shares of Teladoc, Inc. (NYSE:TDOC) opened at 30.70 on Friday. The company’s market capitalization is $1.74 billion. Teladoc, Inc. has a 12-month low of $14.00 and a 12-month high of $36.90. The stock’s 50 day moving average is $34.01 and its 200-day moving average is $27.44.

Teladoc (NYSE:TDOC) last issued its earnings results on Wednesday, August 2nd. The health services provider reported ($0.28) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.26) by $0.02. Teladoc had a negative return on equity of 19.88% and a negative net margin of 47.75%. The company had revenue of $44.60 million for the quarter, compared to the consensus estimate of $44.39 million. During the same quarter in the prior year, the company posted ($0.38) EPS. Teladoc’s revenue was up 68.3% compared to the same quarter last year. Analysts anticipate that Teladoc, Inc. will post ($1.47) earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This piece was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2017/08/11/teladoc-inc-tdoc-insider-sells-1663681-52-in-stock.html.

Several institutional investors have recently modified their holdings of the company. Great West Life Assurance Co. Can bought a new position in shares of Teladoc during the first quarter worth $105,000. US Bancorp DE raised its position in shares of Teladoc by 10.3% in the first quarter. US Bancorp DE now owns 4,617 shares of the health services provider’s stock worth $116,000 after buying an additional 433 shares in the last quarter. Bank of Montreal Can raised its position in shares of Teladoc by 214.2% in the second quarter. Bank of Montreal Can now owns 3,516 shares of the health services provider’s stock worth $123,000 after buying an additional 2,397 shares in the last quarter. Pacad Investment Ltd. bought a new position in shares of Teladoc during the second quarter worth $135,000. Finally, Legal & General Group Plc raised its position in shares of Teladoc by 66.3% in the first quarter. Legal & General Group Plc now owns 6,137 shares of the health services provider’s stock worth $154,000 after buying an additional 2,446 shares in the last quarter. Hedge funds and other institutional investors own 95.88% of the company’s stock.

Several brokerages have commented on TDOC. Cantor Fitzgerald reissued a “hold” rating and issued a $27.00 price target on shares of Teladoc in a report on Monday, June 19th. Canaccord Genuity reissued a “buy” rating and issued a $42.00 price target (up from $34.00) on shares of Teladoc in a report on Tuesday, June 20th. William Blair reissued an “outperform” rating on shares of Teladoc in a report on Tuesday, June 20th. Chardan Capital raised their price target on shares of Teladoc from $30.00 to $41.00 and gave the company a “buy” rating in a report on Tuesday, June 20th. Finally, Piper Jaffray Companies reissued a “buy” rating and issued a $32.00 price target on shares of Teladoc in a report on Friday, July 14th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and ten have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $35.55.

Teladoc Company Profile

Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

Insider Buying and Selling by Quarter for Teladoc (NYSE:TDOC)

Receive News & Stock Ratings for Teladoc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc. and related stocks with our FREE daily email newsletter.